Efficacy of Salvia officinalis extract on the prevention of insulin resistance in euglycemic patients with polycystic ovary syndrome: A double-blinded placebo-controlled clinical trial.

CONCLUSION: S. officinalis extract at a dose of 330 mg/day could decrease BMI and systolic blood pressure, and it could enhance insulin resistance markers in euglycemic PCOS patients. TRIAL REGISTRATION: Iranian Registry of Clinical Trials (IRCT201504146917N2, 2015-10-03). PMID: 31987228 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/31987228?dopt=Abstract

Source: Complementary Therapies in Medicine - December 31, 2019 Category: Complementary Medicine Authors: Amini L, Mojab F, Jahanfar S, Sepidarkish M, Raoofi Z, Maleki-Hajiagha A Tags: Complement Ther Med Source Type: research